Defending substantial equivalence: an argument for the continuing validity of the 510(k) premarket notification process
- PMID: 19601388
Defending substantial equivalence: an argument for the continuing validity of the 510(k) premarket notification process
Similar articles
-
Medical devices; exemptions from premarket notification and reserved devices; class I--FDA. Notice.Fed Regist. 1998 Feb 2;63(21):5387-93. Fed Regist. 1998. PMID: 10177333
-
The need for federal preemption of state tort claims in the context of "new drugs" and premarket-approved medical devices.Seton Hall Law Rev. 2011;41(2):723-63. Seton Hall Law Rev. 2011. PMID: 21739761 No abstract available.
-
Medical devices; exemptions from premarket notification; class II devices; vascular tunnelers. Food and Drug Administration, HHS. Final rule.Fed Regist. 2000 Mar 3;65(43):11466-7. Fed Regist. 2000. PMID: 11010650
-
Left to their own devices: breakdowns in United States medical device premarket review.PLoS Med. 2010 Jul 13;7(7):e1000280. doi: 10.1371/journal.pmed.1000280. PLoS Med. 2010. PMID: 20634922 Free PMC article. Review.
-
Food and Drug Administration regulation of in vitro diagnostic devices.J Mol Diagn. 2005 Feb;7(1):2-7. doi: 10.1016/S1525-1578(10)60002-5. J Mol Diagn. 2005. PMID: 15681468 Free PMC article. Review.
Cited by
-
Roadside Drug Testing Approaches.Molecules. 2021 May 29;26(11):3291. doi: 10.3390/molecules26113291. Molecules. 2021. PMID: 34072538 Free PMC article. Review.
-
Advances in In Vitro and In Vivo Bioreactor-Based Bone Generation for Craniofacial Tissue Engineering.BME Front. 2023 Jan 31;4:0004. doi: 10.34133/bmef.0004. eCollection 2023. BME Front. 2023. PMID: 37849672 Free PMC article. Review.
-
Mapping the genealogy of medical device predicates in the United States.PLoS One. 2021 Oct 7;16(10):e0258153. doi: 10.1371/journal.pone.0258153. eCollection 2021. PLoS One. 2021. PMID: 34618861 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical